Important Announcements

Nondiscrimination Statement Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To see our full nondiscrimination statement, click here.

Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

Molecular genetic tests look carefully at the genetic makeup (DNA) of cells and help pathologists confirm whether a lesion is the result of a cancerous or non-cancerous condition. One type of test is fluorescent in situ hybridization (FISH), which uses fluorescent dyes to identify chromosome abnormalities that are too small to be viewed under a microscope and specific gene changes in a cell. FISH is used on regular blood or bone marrow samples. Unlike standard cytogenetics testing, which may take two to three weeks to yield results, FISH provides accurate results in a matter of days. Another type is polymerase chain reaction (PCR), a highly sensitive DNA test that can detect changes too small to be visible under a microscope.